EUVIMEDEUVIMED entdecken
Open Access

International Pediatric COVID-19 Severity Over the Course of the Pandemic

Yanshan Zhu, Flávia Jacqueline Almeida, J Kenneth Baillie, Asha C Bowen, Philip N Britton, Martin Eduardo Brizuela, Danilo Buonsenso, David Burgner, Keng Yih Chew, Kulkanya Chokephaibulkit, Cheryl Cohen, Stephania A Cormier und 38 weitere

JAMA Pediatrics · 01.10.2023 · 177 (10) · 1073

DOI: 10.1001/jamapediatrics.2023.3117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Pediatrics, erschienen am 01.10.2023. Verfasst von Yanshan Zhu und 49 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Department of Health, Medical Research Council, NCIRD CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Multiple SARS-CoV-2 variants have emerged over the COVID-19 pandemic. The implications for COVID-19 severity in children worldwide are unclear.

Objective

To determine whether the dominant circulating SARS-CoV-2 variants of concern (VOCs) were associated with differences in COVID-19 severity among hospitalized children. Design, Setting, and Participants Clinical data from hospitalized children and adolescents (younger than 18 years) who were SARS-CoV-2 positive were obtained from 9 countries (Australia, Brazil, Italy, Portugal, South Africa, Switzerland, Thailand, UK, and the US) during 3 different time frames. Time frames 1 (T1), 2 (T2), and 3 (T3) were defined to represent periods of dominance by the ancestral virus, pre-Omicron VOCs, and Omicron, respectively. Age groups for analysis were younger than 6 months, 6 months to younger than 5 years, and 5 to younger than 18 years. Children with an incidental positive test result for SARS-CoV-2 were excluded. Exposures SARS-CoV-2 hospitalization during the stipulated time frame. Main Outcomes and Measures The severity of disease was assessed by admission to intensive care unit (ICU), the need for ventilatory support, or oxygen therapy.

Results

Among 31 785 hospitalized children and adolescents, the median age was 4 (IQR 1-12) years and 16 639 were male (52.3%). In children younger than 5 years, across successive SARS-CoV-2 waves, there was a reduction in ICU admission (T3 vs T1: risk ratio [RR], 0.56; 95% CI, 0.42-0.75 [younger than 6 months]; RR, 0.61, 95% CI; 0.47-0.79 [6 months to younger than 5 years]), but not ventilatory support or oxygen therapy. In contrast, ICU admission (T3 vs T1: RR, 0.39, 95% CI, 0.32-0.48), ventilatory support (T3 vs T1: RR, 0.37; 95% CI, 0.27-0.51), and oxygen therapy (T3 vs T1: RR, 0.47; 95% CI, 0.32-0.70) decreased across SARS-CoV-2 waves in children 5 years to younger than 18 years old. The results were consistent when data were restricted to unvaccinated children. Conclusions and Relevance This study provides valuable insights into the impact of SARS-CoV-2 VOCs on the severity of COVID-19 in hospitalized children across different age groups and countries, suggesting that while ICU admissions decreased across the pandemic in all age groups, ventilatory and oxygen support generally did not decrease over time in children aged younger than 5 years. These findings highlight the importance of considering different pediatric age groups when assessing disease severity in COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19AdolescentHumansChildMaleInfantChild, PreschoolFemaleSARS-CoV-2PandemicsOxygen

Substanzen

Oxygen

Autor:innen und Institutionen

  • School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
  • Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.
  • Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil.
  • Hospital Infantil Sabará, Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil.
  • Baillie Gifford Pandemic Science Hub, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
  • Roslin Institute, University of Edinburgh, Easter Bush, Edinburgh, United Kingdom.

Förderung

  • Department of Health
  • Medical Research Council
  • NCIRD CDC HHS
  • Wellcome Trust

Zitieren

APA

Zhu, Y., Almeida, F. J., Baillie, J. K., Bowen, A. C., Britton, P. N., Brizuela, M. E., Buonsenso, D., Burgner, D., Chew, K. Y., Chokephaibulkit, K., Cohen, C., Cormier, S. A., Crawford, N., Curtis, N., Farias, C. G. A., Gilks, C. F., von Gottberg, A., Hamer, D., Jarovsky, D., …, & International Severe Acute Respiratory and Emerging Infection Consortium Comprehensive Clinical Characterisation Collaboration (ISARIC4C) investigatorsPediatri… (2023). International Pediatric COVID-19 Severity Over the Course of the Pandemic. JAMA Pediatrics, 177(10), 1073. https://doi.org/10.1001/jamapediatrics.2023.3117

Vancouver

Zhu Y, Almeida FJ, Baillie JK, Bowen AC, Britton PN, Brizuela ME, et al. International Pediatric COVID-19 Severity Over the Course of the Pandemic. JAMA Pediatrics. 2023;177(10):1073. doi:10.1001/jamapediatrics.2023.3117

BibTeX
@article{Zhu2023,
  author = {Zhu, Yanshan and Almeida, Flávia Jacqueline and Baillie, J Kenneth and Bowen, Asha C and Britton, Philip N and Brizuela, Martin Eduardo and Buonsenso, Danilo and Burgner, David and Chew, Keng Yih and Chokephaibulkit, Kulkanya and Cohen, Cheryl and Cormier, Stephania A and Crawford, Nigel and Curtis, Nigel and Farias, Camila G A and Gilks, Charles F and von Gottberg, Anne and Hamer, Diana and Jarovsky, Daniel and Jassat, Waasila and Jesus, Ana Rita and Kemp, Lisa S and Khumcha, Benjawan and McCallum, Georgina and Miller, Jessica E and Morello, Rosa and Munro, Alasdair P S and Openshaw, Peter J M and Padmanabhan, Srivatsan and Phongsamart, Wanatpreeya and Reubenson, Gary and Ritz, Nicole and Rodrigues, Fernanda and Rungmaitree, Supattra and Russell, Fiona and Sáfadi, Marco A P and Saner, Christoph and Semple, Malcolm G and Prado da Silva, Daniella Gregória Bomfim and de Sousa, Laíse Marine Moura and Diogo Moço Souza, Marília and Spann, Kirsten and Walaza, Sibongile and Wolter, Nicole and Xia, Yao and Yeoh, Daniel K and Zar, Heather J and Zimmermann, Petra and Short, Kirsty R and International Severe Acute Respiratory and Emerging Infection Consortium Comprehensive Clinical Characterisation Collaboration (ISARIC4C) investigatorsPediatri…, International Severe Acute Respiratory and Emerging Infection Consortium Comprehensive Clinical Characterisation Collaboration (ISARIC4C) investigatorsPediatri…},
  title = {International Pediatric COVID-19 Severity Over the Course of the Pandemic},
  journal = {JAMA Pediatrics},
  year = {2023},
  volume = {177},
  number = {10},
  pages = {1073},
  doi = {10.1001/jamapediatrics.2023.3117}
}
Kostenlos starten →